Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands's revenue rose last quarter, but it came up short of analyst expectations. Profit remains elusive, and the company no longer expects positive adjusted free cash flow in fiscal 2024.

Tilray Brands Missed on Revenue in Q3, but This Is the More Concerning Number for Investors

Cronos Group

Curaleaf Holdings, Inc.

The next two years can be make-or-break for the cannabis sector. The biggest speed bump to growth for cannabis companies is not competition, but regulations headwinds.

3 Cannabis Penny Stocks to Buy for 3-Bagger Returns

Innovative Industrial Properties

Trulieve Cannabis Corp.

Cannabis stocks are buzzing with optimism on the back of widespread positive updates. Germany recently legalized pot for recreational use, while Canada is rethinking cannabis taxes.

3 Pot Stocks That Could Make You a Cannabis Millionaire

TLRY stock tumbled after the company reported disappointing quarterly sales and gave a warning to investors. So is now the time to buy?

Is TLRY Stock A Buy As Tilray Plunges On Results And 4/20 Rolls Around?

Canopy Growth

Village Farms International

Marijuana stock investors are seeing the future of cannabis and investing transforming. What does this mean exactly? So from earlier on in the green rush most marijuana stocks traded as if they were never coming down. The excitement of publicly traded cannabis companies being traded on the open market was incredible. Even when slight drops would occur they were often followed by strong recoveries. Now this was back in 2018, and 2019.

These Marijuana Stocks Could Begin To Rise Again?

Tilray missed revenue estimates but beat on earnings for its fiscal third quarter. Top-line growth was driven almost entirely by acquisitions.

Why Tilray Brands Stock Fell 26.9% This Week

Crafted with a blend of Bravo and Simcoe hops, 10 Barrel's New 'Juicy Drama' offers a fresh twist on the traditional Double IPA that fans know and love.

10 Barrel Brewing Adds 'Juicy Drama' to Its Award-Winning HopBurst Family

Tilray Brands Inc. NASDAQ: TLRY is a leading player in the global cannabis industry. The company's earnings report was recently released for the fiscal third quarter of 2024.

Tilray's Q3 Earnings Reveal Growth Despite Challenges

Tilray Brands, Inc. (NASDAQ:TLRY ) Q3 2024 Earnings Conference Call April 9, 2024 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs and Communications Officer Irwin Simon - Chairman and Chief Executive Officer Carl Merton - Chief Financial Officer Denise Faltischek - Chief Strategy Officer and Head of International Blair MacNeil - President, Tilray Canada Ty Gilmore - President, U.S. Beer Business Conference Call Participants Andrew Carter - Stifel Nadine Sarwat - Bernstein Remington Smith - Alliance Global Partners Bill Kirk - Roth MKM Michael Lavery - Piper Sandler Matt Bottomley - Canaccord Genuity Doug Miehm - RBC Capital Markets John Zamparo - CIBC Operator Thank you for joining today's conference call to discuss Tilray Brand's Financial Results for the Third Quarter of Fiscal Year 2024 ended February 29, 2024. All lines have been placed on mute to prevent any background noise.

Tilray Brands, Inc. (TLRY) Q3 2024 Earnings Call Transcript

Turning Point Brands

Slowly but surely, whispers and rumors of widespread cannabis legalization are swirling to the surface. Though cannabis stocks' last big run, in the late 2010s, far eclipses today's market and per-share pricing, we're gradually seeing top cannabis stocks to buy tick upward.

3 Cannabis Stocks on the Brink of a Massive Breakout

Aurora Cannabis

Tilray reported weaker-than-expected sales growth and a big GAAP loss this morning. Competing marijuana stocks are suffering, too.

Why Marijuana Stocks Got Burnt Today

Shares of Tilray Brands (TLRY) plummeted Tuesday after the marijuana products maker and craft beer brewer posted worse-than-expected quarterly results and reduced its full-year earnings guidance as cannabis sales slipped.

Tilray Stock Tanks Following Earnings Miss, Outlook Cut

Tilray reported strong Q3 sales growth -- for alcohol. Marijuana sales are growing too, but not as fast as investors had hoped.

Why Tilray Brands Stock Just Crashed 21.5%

It's been a standout year for marijuana stocks, as the Roundhill Cannabis ETF (BATS: WEED ) is up by over 40% year-to-date. However, Tilray (NASDAQ: TLRY ) stock is falling lower today after reporting its third quarter fiscal year (FY) 2024 earnings.

The 5 Biggest Buyers of Tilray (TLRY) Stock

While the top- and bottom-line numbers for Tilray Brands (TLRY) give a sense of how the business performed in the quarter ended February 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Tilray Brands (TLRY) Q3 Earnings: A Look at Key Metrics

Cannabis company Tilray Brands (NASDAQ: TLRY ) stock fell 15% overnight after management admitted it no longer expects to have a positive free cash flow in fiscal 2024. The bad news came in an earnings release that tried hard to focus on good news about growth and gross profits.

TLRY Stock Alert: Cannabis Legalization Hopes May Not Be Enough for Tilray

Tilray Brands, Inc. (TLRY) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.04 per share a year ago.

Tilray Brands, Inc. (TLRY) Reports Break-Even Earnings for Q3

Tilray Inc (NASDAQ:TLRY) fell over 15% in pre-market trading after the cannabis firm unveiled worse-than-expected losses for the third quarter. Net losses decreased from US$1.2 billion to US$105.0 million year on year, Tilray reported.

Tilray slumps as losses come in worse than expected

Marijuana company Tilray also filed a wider-than-expected loss in the fiscal third quarter, and fell short on sales.

Tilray Brands Stock Dives. Weak Guidance Is Only One Problem.

Tilray Brands Inc.'s stock TLRY, -0.19% fell 11% in premarket trading after the cannabis company reported a wider-than-expected loss in its fiscal third quarter, while revenue fell short of analyst estimates. Tilray said its loss narrowed to $104.98 million, or 12 cents a share, from a loss of $1.2 billion or $1.90 a share, in the year-ago quarter.

Tilray Brands stock drops as it reports wider-than-expected loss and misses on revenue

Tilray Brands Inc (NASDAQ: TLRY) is trading down in premarket on Tuesday after reporting lower than expected revenue for its fiscal third quarter. Tilray stock down on future guidance The cannabis company is in the red this morning also because its management issued downbeat future guidance for the full year.

Tilray no longer expects positive free cash flow in 2024 after Q3 earnings

Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter Beverage-Alcohol Net Revenue Increases 165% Over the Prior Year Quarter, 5th Largest Craft Beer Brewer in the U.S.1 with 4.5% Craft Beer Market Share Global Cannabis Net Revenue Increases 33% with International Cannabis Growth of 44% Over the Prior Year Quarter, #1 Market Share in Canada and #1 Market Share in Germany U.S. Cannabis Strategy in Place to Strike with Potential Drug Policy Reform Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, April 09, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today reported financial results for its third quarter ended February 29, 2024.

Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results

Bitfarms Ltd

Ring Energy

In my view, it's the best time to grab undervalued penny stocks for multibagger returns. The first reason for this view is the point that rate cuts are impending in the second half of 2024.

The 3 Most Undervalued Penny Stocks to Buy in April 2024

Besides Wall Street's top -and-bottom-line estimates for Tilray Brands (TLRY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended February 2024.

Unveiling Tilray Brands (TLRY) Q3 Outlook: Wall Street Estimates for Key Metrics

SNDL Inc.

Cannabis stocks are continuing to rise on good news about legalization. Over the last month, Canopy Growth (NYSE: CGC ) is up 239%, Aurora Cannabis (NYSE: ACB ) is up 127%, SNDL (NASDAQ: SNDL ) is up 81%, Tilray Brands (NASDAQ: TLRY ) is up 68%, and Cronos Group (NASDAQ: CRON ) is up 42%.

News for Tilray Brands Stock (TLRY)